Claude Chelala

10.4k total citations · 1 hit paper
100 papers, 4.3k citations indexed

About

Claude Chelala is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Claude Chelala has authored 100 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 42 papers in Oncology and 37 papers in Cancer Research. Recurrent topics in Claude Chelala's work include Cancer Genomics and Diagnostics (27 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Gene expression and cancer classification (11 papers). Claude Chelala is often cited by papers focused on Cancer Genomics and Diagnostics (27 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Gene expression and cancer classification (11 papers). Claude Chelala collaborates with scholars based in United Kingdom, United States and France. Claude Chelala's co-authors include Nicholas R. Lemoine, Hemant M. Kocher, Abu Z M Dayem Ullah, Jun Wang, Tatjana Crnogorac‐Jurcevic, A. Nagano, John F. Marshall, Arshad Khan, Emanuela Gadaleta and Fieke E. M. Froeling and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Claude Chelala

96 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma

2013 441 citations Jun Wang, John F. Marshall et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claude Chelala United Kingdom	36	2.1k	1.6k	1.0k	692	691	100	4.3k
Cristina Montagna United States	36	3.0k 1.4×	1.4k 0.8×	756 0.7×	505 0.7×	811 1.2×	124	4.8k
E. Aubrey Thompson United States	42	3.3k 1.6×	1.6k 0.9×	1.2k 1.2×	504 0.7×	404 0.6×	112	5.0k
Deborah L. French United States	38	2.4k 1.2×	741 0.4×	1.0k 1.0×	1.0k 1.5×	539 0.8×	134	5.3k
Pepper Schedin United States	46	2.0k 1.0×	3.5k 2.1×	1.5k 1.4×	882 1.3×	733 1.1×	119	6.2k
Peter Oettgen United States	46	3.3k 1.6×	953 0.6×	1.1k 1.1×	888 1.3×	437 0.6×	85	5.8k
Hendrik Ungefroren Germany	41	2.9k 1.4×	2.3k 1.4×	1.0k 1.0×	1.2k 1.7×	262 0.4×	130	5.4k
Gustavo Baldassarre Italy	40	3.4k 1.6×	1.6k 1.0×	1.8k 1.7×	432 0.6×	374 0.5×	134	5.1k
Gonzalo Goméz-López Spain	43	3.9k 1.9×	1.1k 0.7×	1.3k 1.2×	719 1.0×	383 0.6×	111	6.2k
Tae‐Min Kim South Korea	43	2.6k 1.2×	1.4k 0.9×	1.8k 1.7×	493 0.7×	728 1.1×	166	5.5k
Raymond S. Yeung United States	45	3.2k 1.5×	1.7k 1.0×	844 0.8×	552 0.8×	639 0.9×	131	6.6k

Countries citing papers authored by Claude Chelala

Since Specialization

Citations

This map shows the geographic impact of Claude Chelala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Chelala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Chelala more than expected).

Fields of papers citing papers by Claude Chelala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Chelala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Chelala. The network helps show where Claude Chelala may publish in the future.

Co-authorship network of co-authors of Claude Chelala

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Chelala. A scholar is included among the top collaborators of Claude Chelala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Chelala. Claude Chelala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ang, Andrew, et al.. (2024). Prognostication for recurrence patterns after curative resection for pancreatic ductal adenocarcinoma. Annals of Hepato-Biliary-Pancreatic Surgery. 28(2). 248–261. 3 indexed citations

Phillips, Melissa, Michael D. Allen, Essam Ghazaly, et al.. (2023). A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma. Pharmacological Reports. 75(3). 570–584. 4 indexed citations

Gadaleta, Emanuela, et al.. (2023). Dynamic Biobanking for Advancing Breast Cancer Research. Journal of Personalized Medicine. 13(2). 360–360. 4 indexed citations

Gadaleta, Emanuela, Graeme J. Thorn, Helen Ross‐Adams, J. Louise Jones, & Claude Chelala. (2022). Field cancerization in breast cancer. The Journal of Pathology. 257(4). 561–574. 42 indexed citations

Baleeiro, Renato B., Peng Liu, Louisa S. Chard, et al.. (2022). MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy. OncoImmunology. 11(1). 2080329–2080329. 21 indexed citations

Banerjee, Abhirup, Amina Sâad, Ahmet Imrali, et al.. (2022). Differentiating Ductal Adenocarcinoma of the Pancreas from Benign Conditions Using Routine Health Records: A Prospective Case-Control Study. Cancers. 15(1). 280–280. 3 indexed citations

Marzec, Jacek, Helen Ross‐Adams, S Pirro, et al.. (2021). The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis. Cancers. 13(2). 345–345. 7 indexed citations

Montero‐Melendez, Trinidad, A. Nagano, Claude Chelala, et al.. (2020). Therapeutic senescence via GPCR activation in synovial fibroblasts facilitates resolution of arthritis. Nature Communications. 11(1). 745–745. 48 indexed citations

Keane, Lily, Sean‐Patrick Riechers, Raphaël Zollinger, et al.. (2020). mTOR-dependent translation amplifies microglia priming in aging mice. Journal of Clinical Investigation. 131(1). 62 indexed citations

10.

Sivapalan, Lavanya, Hemant M. Kocher, Helen Ross‐Adams, & Claude Chelala. (2020). Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application. Pancreatology. 21(2). 363–378. 41 indexed citations

11.

Pirro, S, Emanuela Gadaleta, Andrea Galgani, Vittorio Colizzi, & Claude Chelala. (2019). SMAC, a computational system to link literature, biomedical and expression data. Scientific Reports. 9(1). 10480–10480. 56 indexed citations

12.

Carter, Edward, Edmund H. Wilkes, Ann‐Marie Baker, et al.. (2018). PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer. Cell Reports. 22(9). 2469–2481. 38 indexed citations

13.

Wang, Jun, Laurent Dumartin, Andrea Mafficini, et al.. (2017). Splice variants as novel targets in pancreatic ductal adenocarcinoma. Scientific Reports. 7(1). 2980–2980. 31 indexed citations

14.

Wang, Jun, Eleni Maniati, James A. Heward, et al.. (2016). Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma. Cancer Research. 76(16). 4861–4871. 72 indexed citations

15.

Morrissey, Bethny, Ingunn Holen, Claude Chelala, et al.. (2016). Introducing SEARCHBreast: a virtual resource to facilitate sharing of surplus animal material developed for breast cancer research. npj Breast Cancer. 2(1). 16020–16020. 1 indexed citations

16.

Ullah, Abu Z M Dayem, Rosalind Cutts, Emanuela Gadaleta, et al.. (2013). The pancreatic expression database: recent extensions and updates. Nucleic Acids Research. 42(D1). D944–D949. 23 indexed citations

17.

Flak, Magdalena B., Claire M. Connell, Claude Chelala, et al.. (2010). p21 promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker. Molecular Cancer. 9(1). 175–175. 18 indexed citations

18.

Wang, Yaohe, Rathi Gangeswaran, Pengju Wang, et al.. (2009). CEACAM6 attenuates adenovirus infection by antagonizing viral trafficking in cancer cells. Journal of Clinical Investigation. 119(6). 1604–1615. 26 indexed citations

19.

Yuan, Ming, Romain Lara, Deborah L. Holliday, et al.. (2008). Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death and Differentiation. 15(11). 1752–1759. 271 indexed citations

20.

Senée, Valérie, Claude Chelala, Sabine Duchatelet, et al.. (2006). Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nature Genetics. 38(6). 682–687. 270 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact